Researchers Identify Complete Bacterial Pathway for Converting Bilirubin to Urobilinogen in Human Gut
Scientists have identified the complete enzymatic pathway by which gut bacteria convert bilirubin (a heme breakdown product) into urobilinogen, involving two enzymes: BilR and BilV. The discovery reveals that bilirubin metabolism requires two sequential reactions that can occur in either order, with BilV being a flavin-dependent enzyme widely distributed across gut bacteria. This finding is significant because bilirubin and its derivatives are linked to inflammatory and metabolic disorders, and understanding this pathway could enable better studies of how gut bacteria influence human health.
Researchers have mapped the complete bacterial pathway for converting bilirubin—the primary product of heme breakdown in mammals—into urobilinogen in the human gut microbiome. The study identifies two key enzymes responsible for this conversion: BilR, which reduces the methine bridges of bilirubin to form an intermediate called divinylurobilinogen, and BilV, a flavin-dependent oxidoreductase from the Old Yellow Enzyme superfamily that reduces vinyl groups. The two reactions can occur in either order, and the researchers used transcriptomic profiling to identify BilV and characterize its distribution across human gut bacteria. While BilR and BilV distributions overlap, they do not completely mirror each other, suggesting functional redundancy or specialization among bacterial species. Since bilirubin and its metabolic derivatives are associated with susceptibility to inflammatory and metabolic disorders, this pathway characterization enables future research into how microbial metabolism of bilirubin contributes to human health and disease.
What's missing
The study does not discuss potential therapeutic applications or whether dysbiosis (altered microbiota composition) affecting BilR or BilV-expressing bacteria could contribute to disease pathogenesis. Additionally, the paper does not address whether the identified pathway is conserved in non-human mammals or how individual variation in gut bacterial composition might affect bilirubin metabolism rates across human populations.
What different sources said
- bioRxivCenter
Identification of the complete pathway for conversion of bilirubin to urobilinogen by human gut bacteria
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.